Farnesyltransferase Inhibitors in Cancer Therapy
- List Price: $249.00
- Binding: Hardcover
- Publisher: Humana Pr Inc
- Publish date: 11/01/2000
Description:
The recent explosion of knowledge gained from genes capable of causing cancer, and the pivotal role they play in growth factor signal transduction have opened up new avenues for rationally designing novel anticancer drugs. Recently, scientists have realized that a signal transduction process called farnesylation is required to occur in order to prompt cancer-causing activity. Thus begun an intense search for farnelesyltransferase inhibitors as novel anticancer agents. This volume describes the efforts of several groups in the design, synthesis, and evaluation of these inhibitors.
Expand description
Product notice
Returnable at the third party seller's discretion and may come without consumable supplements like access codes, CD's, or workbooks.
Please Wait